Skip to main content
. Author manuscript; available in PMC: 2021 Sep 28.
Published in final edited form as: J Interv Cardiol. 2018 Sep 10;31(6):849–860. doi: 10.1111/joic.12561

TABLE 4.

Characteristics of patients with low gradient low stroke volume index, low gradient normal stroke volume index, and high gradient severe aortic stenosis in the setting of normal left ventricular ejection fraction

Low gradient low stroke volume index (n = 41) Low gradient normal stroke volume index (n = 32) High gradient stenosis (n = 229) P-value
Age, years 84 [80–90] 84 [78–89] 84 [80–88] 0.75
Male sex 22 (53.7%) 19 (59.4%) 117 (51.1%) 0.67
Race 0.69
 White 40 (97.6%) 30 (93.8%) 203 (89.0%)
 Black 0 1 (3.1%) 10 (4.4%)
 Asian 0 0 3 (1.3%)
 Other 1 (2.4%) 1 (3.1%) 12 (5.3%)
Ethnicity
 Hispanic 1 (2.4%) 1 (3.1%) 15 (6.6%) 0.46
Body mass index, kg/m2 26.8 [24.6–29.8] 24.4 [22.2–27.3] 26.6 [23.6–30.8] 0.03
History of tobacco use 22 (56.4%) 14 (43.8%) 112 (50.0%) 0.57
Hypertension 33 (80.5%) 23 (71.9%) 179 (78.2%) 0.66
Dyslipidemia 32 (78.0%) 21 (65.6%) 174 (76.3%) 0.39
Diabetes mellitus 18 (43.9%) 7 (21.9%) 70 (30.6%) 0.11
Prior myocardial infarction 6 (15.0%) 3 (9.4%) 17 (7.5%) 0.29
Prior cardiac surgery 12 (29.3%) 8 (25.0%) 58 (25.4%) 0.87
Prior surgical aortic valve replacement 1 (2.5%) 2 (6.3%) 14 (6.2%) 0.64
Congestive heart failure 35 (85.4%) 28 (87.5%) 197 (86.4%) 0.97
Chronic lung disease 10 (24.4%) 8 (25.0%) 57 (25.1%) 0.99
Atrial arrhythmia 22 (53.7%) 8 (25.0%) 65 (28.5%) 0.004
Prior permanent pacemaker placement 7 (17.1%) 5 (15.6%) 26 (11.5%) 0.53
Prior stroke or transient ischemic attack 9 (22.0%) 7 (21.9%) 26 (11.4%) 0.08
Chronic renal insufficiency 24 (61.5%) 13 (41.9%) 108 (48.6%) 0.22
Number of native coronary arteries diseased 0.64
 0 17 (45.9%) 19 (59.4%) 128 (60.4%)
 1 12 (32.4%) 6 (18.8%) 39 (18.4%)
 2 3 (8.1%) 3 (9.4%) 18 (8.5%)
 3 5 (13.5%) 4 (12.5%) 27 (12.7%)
Society of Thoracic Surgery predicted 30-day mortality risk, % 6.3 [3.8–8.1] 6.0 [4.3–8.1] 5.7 [4.1–7.4] 0.74
Aortic valve peak velocity, m/sec 3.5 [3.2–3.7] 3.6 [3.4–3.8] 4.3 [4.1–4.7] <0.001
Mean gradient, mmHg 26 [22–31] 30 [25–31] 44 [40–55] <0.001
Aortic valve area, cm2 0.70 [0.66–0.80] 0.83 [0.75–0.91] 0.70 [0.57–0.80] <0.001
Left ventricular ejection fraction, % 65 [60–70] 65 [60–70] 65 [60–70] 0.92
Left ventricular end-diastolic dimension, cm 4.1 [3.9–4.8] 4.2 [3.4–4.6] 4.2 [3.7–4.7] 0.69
Left ventricular end-systolic diameter, cm 2.9 [2.4–3.4] 2.6 [2.2–3.0] 2.8 [2.4–3.1] 0.09
Interventricular septum thickness, cm 1.3 [1.1–1.5] 1.4 [1.2–1.5] 1.3 [1.2–1.5] 0.86
Posterior/inferolateral wall thickness, cm 1.2 [1.0–1.3] 1.2 [1.1–1.3] 1.2 [1.1–1.3] 0.26
Aortic regurgitation (moderate or severe), % 2 (4.9%) 4 (12.5%) 20 (8.7%) 0.51
Mitral regurgitation (moderate or severe), % 11 (26.8%) 5 (15.6%) 31 (13.5%) 0.10
Mitral stenosis (severe), % 0 0 7 (3.3%) 0.33
Tricuspid regurgitation (severe), % 2 (4.9%) 0 4 (1.7%) 0.29
Aortic root, cm 3.1 [2.9–3.3] 3.0 [2.8–3.4] 3.1 [2.8–3.4] 0.70
Procedure status, %
 Elective 40 (97.6%) 31 (96.9%) 218 (95.2%) 0.74
 Urgent 1 (2.4%) 1 (3.1%) 11 (4.8%)
 Emergency/Salvage 0 0 0
Access, % 0.02
 Transfemoral 40 (97.6%) 30 (93.8%) 228 (99.6%)
 Transapical 1 (2.4%) 1 (3.1%) 1 (0.4%)
 Subclavian 0 1 (3.1%) 0
Anesthesia, % 0.12
 Monitored anesthesia care 36 (87.8%) 25 (78.1%) 207 (90.4%)
 General anesthesia 5 (12.2%) 7 (21.9%) 22 (9.6%)
Device, % 0.06
 1st generation self-expanding valve 13 (31.7%) 8 (25.0%) 61 (26.6%)
 2nd generation self-expanding valve 16 (39.0%) 18 (56.3%) 115 (50.2%)
 1st generation balloon-expandable valve 5 (12.2%) 4 (12.5%) 8 (3.5%)
 2nd generation balloon—expandable valve 7 (17.1%) 2 (6.3%) 45 (19.7%)
Predilation, % 11 (26.8%) 5 (16.1%) 75 (32.8%) 0.15
Postdilation, % 9 (22.0%) 11 (35.5%) 98 (42.8%) 0.04

Continuous data shown as median [interquartile range] and compared using Kruskal-Wallis test. Categorical data shown as frequency (proportion) and compared using tests of proportions